Meeting to be held in New York on November 12-13 hosted by Oppenheimer.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRY:
- ARS Pharmaceuticals price target lowered to $35 from $40 at Oppenheimer
- ARS Pharmaceuticals Reports Strong Q3 2025 Growth
- Ars Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
- Promising Outlook for ARS Pharmaceuticals: Buy Rating Affirmed by Lachlan Hanbury Brown
- ARS Pharmaceuticals Reports Q3 2025 Financial Results